AMSTERDAM – The European Union’s medicines agency announced Thursday that it has moved forward a meeting to consider authorizing a coronavirus vaccine made by Moderna for use in the 27-nation bloc.The Amsterdam-based agency, which is meeting Monday to consider authorizing a vaccine made by Pfizer Inc.
and German company BioNTech for use in the EU, had scheduled a meeting to discuss the Moderna vaccine on Jan. 12, but that has now been brought forward to Jan.